Gilead Sciences, Inc. vs Public Storage — how do they compare? Gilead Sciences, Inc. trades at $135.49 (market cap $168.35B), while Public Storage trades at $324.41 (market cap $60.71B). The key difference: Gilead Sciences, Inc. is far larger — about 2.8× Public Storage's market cap, and Public Storage pays the higher dividend (3.69%). Which is the better fit depends on your goals.
| GILD | PSA | |
|---|---|---|
Market Cap | $168.35B | $60.71B |
Sector | Health | Real Estate |
52-Week High | $155.80 | $330.47 |
52-Week Low | $110.56 | $258.44 |
Enterprise Value | $191.42B | $74.98B |
Dividend Yield | 2.42% | 3.69% |
Trailing returns across standard periods
Latest headlines on both assets
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →